by Dr. Michael Garin | Apr 3, 2025 | Eye Care
Lumithera Valeda is an excellent treatment option for individuals in the early to intermediate stages of dry macular degeneration. If you’ve experienced gradual vision loss, difficulty reading, or a decrease in your central vision, this light therapy may help slow the...
by Dr. Michael Garin | Mar 27, 2025 | Eye Care, Eye Conditions
The Lumithera Valeda treatment uses photobiomodulation therapy to deliver low-level light to the retina, which stimulates mitochondrial activity in retinal cells. This process helps to reduce oxidative stress and inflammation, two major contributors to the progression...
by Dr. Michael Garin | Mar 20, 2025 | Eye Care, Macular Degeneration
Burman and Zuckerbrod Ophthalmology is proud to announce that we’re one of only 14 practices nationwide offering the groundbreaking Lumithera Valeda treatment for dry macular degeneration (AMD). Recently approved by the FDA, this innovative therapy manages a condition...
by Dr. Michael Garin | Mar 13, 2025 | Eye Care, Eye Conditions, Macular Degeneration
The Valeda Lumithera device is one of the first treatments specifically designed to combine photobiomodulation (PBM) therapy with the treatment of dry macular degeneration (AMD). This innovative, non-invasive device uses light-based technology to target the underlying...
by Dr. Michael Garin | Mar 6, 2025 | Eye Care, Eye Conditions, Macular Degeneration
Photobiomodulation (PBM) therapy, also known as low-level light therapy (LLLT), is a groundbreaking treatment that utilizes specific wavelengths of light to stimulate cellular processes, promote healing, and reduce inflammation. PBM has shown great promise in various...
by Dr. Michael Garin | Feb 27, 2025 | Eye Care, Macular Degeneration
Age-related macular degeneration (AMD) is one of the leading causes of vision impairment, particularly in individuals over the age of 50. The condition affects the macula, the central part of the retina responsible for sharp vision. AMD is categorized into two forms:...
